|
|
| MRD / Regn No. |
: MH/23-24/02773 |
Date |
: 08/06/2026 |
| Patient Name |
: Mr Venkatesan |
Age & Gender |
: 66 Yrs. / Male |
| Contact No. |
: 8870712358 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NO ALLERGIES |
Referred By |
: |
| |
|
| Problem
List |
: |
NEWLY DIAGNOSED DM (08/Jun/2026) | CELLULITIS (08/Jun/2026) | |
|
Subjective |
: |
SWELLING & PAIN RT LEG |
|
Objective |
: |
SWELLING++/TENDERNESS++ |
| Salient Investigations |
: |
HB HEMOGLOBIN: 14.3 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 7 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 180 100 | UREA: 36 mg/dL | CREATININE: 1.43 1 | EGFR EGLOMERULAR FILTRATION RATE: 52.66 mL/min/1.73m2 | TOTAL CHOLESTEROL: 169 1 | LDL LOW DENSITY LIPOPROTEIN: 90 mg/dL | TGL TRIGLYCERIDE: 160 mg/dL | HDL HIGH DENSITY LIPOPROTEIN: 48 mg/dL | TOTAL BILIRUBIN: 0.47 mg/dL | DIRECT BILIRUBIN: 0.23 mg/DL | INDIRECT BILURUBIN: 0.24 | AST ASPARTATE AMINOTRANSFERASE: 59 U/L | ALBUMIN: 4.25 g/dL | GLOBULIN: 3.11 | TOTAL T3: 97 1 | TOTAL T4: 5.21 1 | TSH THYROID STIMULATING HORMONE: 2.21 mIU/L | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TABLET VILDAGLIPTIN + METFORMIN 500
VILDAR - M |
ORAL |
1-0-1 |
AFTER FOOD
|
TILL NEXT VISIT |
|
|
2 |
TABLET DAPAGLIFLOZIN 10
DAPAKAD 10 |
ORAL |
0-0-1 |
AFTER FOOD
|
TILL NEXT VISIT |
|
|
3 |
TABLET ROSUVASTATIN 5 MG
ROSUWIN 5
Medicine For CHOLESTROL/HEART |
ORAL |
0-0-1 |
AFTER FOOD
|
TILL NEXT VISIT |
|
|
4 |
CAPSULE TAMOLOZIN HYDROCHLORIDE 0.4
TAMSWIN 0.4MG |
|
0-0-1 |
|
|
|
|
5 |
TABLET TELMISARTAN 40
TELDAR 40 |
ORAL |
1-0-0 |
AFTER FOOD
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 08/Jul/2026 |
| Tests Suggested For Next Visit |
: |
| |
|
| |
|
